- Home
- REE vs KYTX Comparison
REE vs KYTX Comparison
Compare REE & KYTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REE
- KYTX
- Stock Information
- Founded
- REE 2011
- KYTX 2018
- Country
- REE Israel
- KYTX United States
- Employees
- REE N/A
- KYTX N/A
- Industry
- REE Auto Manufacturing
- KYTX
- Sector
- REE Consumer Discretionary
- KYTX
- Exchange
- REE Nasdaq
- KYTX NYSE
- Market Cap
- REE 77.3M
- KYTX 92.1M
- IPO Year
- REE N/A
- KYTX 2024
- Fundamental
- Price
- REE $0.61
- KYTX $2.82
- Analyst Decision
- REE Strong Buy
- KYTX Strong Buy
- Analyst Count
- REE 2
- KYTX 5
- Target Price
- REE $11.75
- KYTX $19.00
- AVG Volume (30 Days)
- REE 230.1K
- KYTX 587.4K
- Earning Date
- REE 07-11-2025
- KYTX 08-11-2025
- Dividend Yield
- REE N/A
- KYTX N/A
- EPS Growth
- REE N/A
- KYTX N/A
- EPS
- REE N/A
- KYTX N/A
- Revenue
- REE $183,000.00
- KYTX N/A
- Revenue This Year
- REE $7,039.34
- KYTX N/A
- Revenue Next Year
- REE $2,159.93
- KYTX N/A
- P/E Ratio
- REE N/A
- KYTX N/A
- Revenue Growth
- REE N/A
- KYTX N/A
- 52 Week Low
- REE $0.53
- KYTX $1.78
- 52 Week High
- REE $11.72
- KYTX $11.40
- Technical
- Relative Strength Index (RSI)
- REE 30.19
- KYTX 46.89
- Support Level
- REE $0.53
- KYTX $2.97
- Resistance Level
- REE $0.64
- KYTX $3.75
- Average True Range (ATR)
- REE 0.04
- KYTX 0.32
- MACD
- REE 0.07
- KYTX -0.07
- Stochastic Oscillator
- REE 36.87
- KYTX 10.38
About REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is developing REEcorner technology which packs critical vehicle components into a single compact module positioned between the chassis and the wheel as well as building commercial Electric Vehicles (EV) leveraging REEcorner technology. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.
About KYTX KYVERNA THERAPEUTICS INC
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.